Ocumension Therapeutics

NEW
HKSE:01477 (China)   Ordinary Shares
HK$ 5.38 +0.055 (+1.03%) Sep 14
At Loss
P/B:
1.06
Market Cap:
HK$ 4.33B ($ 551.94M)
Enterprise V:
HK$ 3.91B ($ 498.30M)
Volume:
267.51K
Avg Vol (2M):
1.00M
Trade In:
Volume:
267.51K
At Loss
Avg Vol (2M):
1.00M

Ocumension Therapeutics (HKSE:01477) Dividend

Ocumension Therapeutics (HKSE:01477) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -5.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: HKSE:01477 Dividend

Does Ocumension Therapeutics (HKSE:01477) pay a dividend?

Ocumension Therapeutics (HKSE:01477) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Ocumension Therapeutics pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Ocumension Therapeutics has returned capital to shareholders via buybacks at a rate of -5.3% over the past 3 years.

What are dividend-paying alternatives to Ocumension Therapeutics?

For dividend-paying alternatives in Ocumension Therapeutics's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.